---
title: "Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286822292.md"
description: "Profusa has submitted an advance notice to Ascent Partners Fund for the purchase of up to 9.99% of its outstanding shares, capped at $300,000. The purchase price will be based on 97% of the lowest 10-day VWAP, with a true-up mechanism to issue additional shares if necessary. This is part of their equity line agreement."
datetime: "2026-05-18T21:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286822292.md)
  - [en](https://longbridge.com/en/news/286822292.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286822292.md)
---

# Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism

**Profusa requested Ascent Partners Fund to purchase shares under their equity line with new pricing and true-up terms.**

**Key Highlights:**

-   Submitted Advance Notice asking Ascent to buy up to 9.99% of outstanding shares per notice, capped at $300,000.
-   Purchase price funded upon delivery of shares; Ascent remits within one trading day 97% of the lowest 10-day VWAP times shares.
-   Includes a True-Up Mechanism: if 97% of the lowest VWAP during the Adjustment Period is below the closing price, Profusa will issue additional shares so Ascent receives the equivalent number.

Original SEC Filing: Profusa, Inc. \[ PFSA \] - 8-K - May. 18, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [NVACW.US](https://longbridge.com/en/quote/NVACW.US.md)

## Related News & Research

- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)